NFL BIOSCIENCES confirme le renouvellement de son éligibilité au PEA-PME
July 11, 2022 11:45 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES confirme le renouvellement de son éligibilité au PEA-PME NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments...
NFL BIOSCIENCES : PARTICIPATION À LA H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE
June 24, 2022 12:00 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES : PARTICIPATION À LA H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des...
NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE
June 24, 2022 12:00 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical...
NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31
May 25, 2022 02:00 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES, which is committed to the fight against smoking, fully supports World No Tobacco Day on May 31 NFL BIOSCIENCES, a biopharmaceutical company developing botanical drugs for the...
NFL BIOSCIENCES, engagé dans la lutte contre le tabagisme, souscrit pleinement à la Journée Mondiale Sans Tabac du 31 mai
May 25, 2022 02:00 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES, engagé dans la lutte contre le tabagisme, souscrit pleinement à la Journée Mondiale Sans Tabac du 31 mai NFL BIOSCIENCES, société biopharmaceutique développant des médicaments...
NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea
May 11, 2022 12:15 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs...
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Corée du Sud
May 11, 2022 12:15 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Corée du Sud NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments...
NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2021
April 29, 2022 11:45 ET
|
NFL BIOSCIENCES
NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2021 NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments botaniques...
NFL BIOSCIENCES: Notice of allowance of its patent in China
April 11, 2022 12:00 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES: Notice of allowance of its patent in China NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of...
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Chine
April 11, 2022 12:00 ET
|
NFL BIOSCIENCES
NFL BIOSCIENCES : Décision d’accord de délivrance de son brevet en Chine NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments...